Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Acta Psychiatr Scand

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    July 2022
  1. BENROS ME
    High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis.
    Acta Psychiatr Scand. 2022;146:3-5.
    PubMed    


    May 2022
  2. FACAL F, Arrojo M, Paz E, Paramo M, et al
    Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Acta Psychiatr Scand. 2022 May 18. doi: 10.1111/acps.13444.
    PubMed     Abstract available


    April 2022
  3. BAANDRUP L, Allerup P, Nielsen MO, During SW, et al
    Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.
    Acta Psychiatr Scand. 2022 Apr 13. doi: 10.1111/acps.13434.
    PubMed     Abstract available


    March 2022
  4. SPILKA MJ, Keller WR, Buchanan RW, Gold JM, et al
    Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.
    Acta Psychiatr Scand. 2022 Mar 4. doi: 10.1111/acps.13421.
    PubMed     Abstract available


    February 2022
  5. DUNLEAVY C, Elsworthy RJ, Upthegrove R, Wood SJ, et al
    Inflammation in First-Episode Psychosis: The Contribution of Inflammatory Biomarkers to the Emergence of Negative Symptoms, A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2022 Feb 24. doi: 10.1111/acps.13416.
    PubMed     Abstract available


  6. MORENO-KUSTNER B, Fabrega-Ruz J, Gonzalez-Caballero JL, Reyes S, et al
    The Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS): Development and Validation.
    Acta Psychiatr Scand. 2022 Feb 21. doi: 10.1111/acps.13417.
    PubMed     Abstract available


  7. VERDOLINI N, Borras R, Sparacino G, Garriga M, et al
    The prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood.
    Acta Psychiatr Scand. 2022 Feb 16. doi: 10.1111/acps.13415.
    PubMed     Abstract available


  8. BRODEUR S, Vanasse A, Courteau J, Stip E, et al
    Comparative Effectiveness and Safety of Antipsychotic Drugs in Patients with Schizophrenia Initiating or Reinitiating Treatment: A Real-World Observational Study.
    Acta Psychiatr Scand. 2022 Feb 14. doi: 10.1111/acps.13413.
    PubMed     Abstract available


  9. TESLI M, Degerud E, Plana-Ripoll O, Gustavson K, et al
    Educational attainment and mortality in schizophrenia.
    Acta Psychiatr Scand. 2022 Feb 13. doi: 10.1111/acps.13407.
    PubMed     Abstract available


  10. BRODEUR S, Vanasse A, Courteau J, Courteau M, et al
    Antipsychotic Utilization Trajectories Three Years After Initiating or Reinitiating Treatment of Schizophrenia: A State Sequence Analysis Approach.
    Acta Psychiatr Scand. 2022 Feb 12. doi: 10.1111/acps.13411.
    PubMed     Abstract available


    January 2022
  11. MURILLO-GARCIA N, Diaz-Pons A, Fernandez-Cacho LM, Miguel-Cossrredera M, et al
    A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype.
    Acta Psychiatr Scand. 2022 Jan 25. doi: 10.1111/acps.13404.
    PubMed     Abstract available


  12. BALLESTER PL, Romano MT, de Azevedo Cardoso T, Hassel S, et al
    Brain age in mood and psychotic disorders: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2022;145:42-55.
    PubMed     Abstract available


    December 2021
  13. LOPEZ-DIAZ A, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3-year longitudinal study.
    Acta Psychiatr Scand. 2021;144:578-588.
    PubMed     Abstract available


    November 2021
  14. NIELSEN J
    Clozapine treatment in a wider context: From before eligibility to life beyond clozapine.
    Acta Psychiatr Scand. 2021;144:419-421.
    PubMed    


  15. SISKIND D, Sharma M, Pawar M, Pearson E, et al
    Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.
    Acta Psychiatr Scand. 2021;144:422-432.
    PubMed     Abstract available


    October 2021
  16. MUSTAFA SS, Malla A, Joober R, Abadi S, et al
    Unfinished business: Functional outcomes in a randomized controlled trial of a three-year extension of early intervention versus regular care following two years of early intervention for psychosis.
    Acta Psychiatr Scand. 2021 Oct 2. doi: 10.1111/acps.13377.
    PubMed     Abstract available


    September 2021
  17. PARK CI, Han M, Jung I, Kim EH, et al
    A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia.
    Acta Psychiatr Scand. 2021 Sep 26. doi: 10.1111/acps.13375.
    PubMed     Abstract available


    August 2021
  18. SMITH E, Singh R, Lee J, Colucci L, et al
    Adiposity in Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Aug 30. doi: 10.1111/acps.13365.
    PubMed     Abstract available


  19. KRISTENSEN TD, Glenthoj LB, Ambrosen K, Syeda W, et al
    Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis.
    Acta Psychiatr Scand. 2021 Aug 1. doi: 10.1111/acps.13355.
    PubMed     Abstract available


  20. HSU CW, Tseng PT, Tu YK, Lin PY, et al
    Month of birth and mental disorders: A population-based study and validation using global meta-analysis.
    Acta Psychiatr Scand. 2021;144:153-167.
    PubMed     Abstract available


    July 2021
  21. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    PubMed     Abstract available


  22. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    PubMed     Abstract available


  23. BARCELLA CA, Polcwiartek C, Mohr GH, Hodges G, et al
    Severe mental illness is associated with increased mortality and severe course of COVID-19.
    Acta Psychiatr Scand. 2021;144:82-91.
    PubMed     Abstract available


    June 2021
  24. BHAVSAR V, Kepinska AP
    Schizophrenia, catatonic schizophrenia and poliovirus - a role for natural experiments?
    Acta Psychiatr Scand. 2021;143:469-471.
    PubMed    


    May 2021
  25. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    PubMed     Abstract available


    April 2021
  26. MARWAHA S, Hett D, Johnson S, Fowler D, et al
    The impact of manic symptoms in first-episode psychosis: findings from the UK National EDEN study.
    Acta Psychiatr Scand. 2021 Apr 16. doi: 10.1111/acps.13307.
    PubMed     Abstract available


  27. SANKARANARAYANAN A, Pratt R, Anoop A, Smith A, et al
    Serum Lipids and Suicidal Risk among Patients with Schizophrenia Spectrum Disorders: Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Apr 9. doi: 10.1111/acps.13305.
    PubMed     Abstract available


  28. WHISKEY E, Barnard A, Oloyede E, Dzahini O, et al
    An evaluation of the variation and underuse of clozapine in the United Kingdom.
    Acta Psychiatr Scand. 2021;143:339-347.
    PubMed     Abstract available


    March 2021
  29. HANIN C, Arnulf I, Maranci JB, Lecendreux M, et al
    Narcolepsy and psychosis: a systematic review.
    Acta Psychiatr Scand. 2021 Mar 29. doi: 10.1111/acps.13300.
    PubMed     Abstract available


  30. ANTTI T, Heidi T, Mary C, David C, et al
    Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases.
    Acta Psychiatr Scand. 2021 Mar 13. doi: 10.1111/acps.13295.
    PubMed     Abstract available


  31. LAHTEENVUO M, Batalla A, Luykx JJ, Mittendorfer-Rutz E, et al
    Morbidity and mortality in schizophrenia with comorbid substance use disorders.
    Acta Psychiatr Scand. 2021 Mar 1. doi: 10.1111/acps.13291.
    PubMed     Abstract available


  32. VAN DER ZALM Y, Foldager L, Termorshuizen F, Sommer IE, et al
    Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
    Acta Psychiatr Scand. 2021;143:216-226.
    PubMed     Abstract available


  33. YADA Y, Kitagawa K, Sakamoto S, Ozawa A, et al
    The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study.
    Acta Psychiatr Scand. 2021;143:227-237.
    PubMed     Abstract available


    February 2021
  34. FORNARO M
    There are no "side" effects, just "core" effects of antipsychotic pharmacotherapy.
    Acta Psychiatr Scand. 2021;143:99-100.
    PubMed    


    January 2021
  35. TAYLOR CL, Brown HK, Saunders NR, Barker LC, et al
    Accidental injury, self-injury and assault among children of women with schizophrenia: a population-based cohort study.
    Acta Psychiatr Scand. 2021 Jan 27. doi: 10.1111/acps.13281.
    PubMed     Abstract available


  36. SALAGRE E, Grande I, Jimenez E, Mezquida G, et al
    Trajectories of suicidal ideation after first-episode psychosis: a growth mixture modeling approach.
    Acta Psychiatr Scand. 2021 Jan 27. doi: 10.1111/acps.13279.
    PubMed     Abstract available


    December 2020
  37. WAKUDA T, Takei N
    'Opening doors' for long-term institutionalised patients with schizophrenia in Japan.
    Acta Psychiatr Scand. 2020 Dec 19. doi: 10.1111/acps.13269.
    PubMed     Abstract available


    November 2020
  38. HOLM M, Taipale H, Tanskanen A, Tiihonen J, et al
    Employment among people with schizophrenia or bipolar disorder: a population-based study using nationwide registers.
    Acta Psychiatr Scand. 2020 Nov 5. doi: 10.1111/acps.13254.
    PubMed     Abstract available


    July 2020
  39. PERRY BI, Upthegrove R, Crawford O, Jang S, et al
    Cardiometabolic Risk Prediction Algorithms for Young People with Psychosis: A Systematic Review and Exploratory Analysis.
    Acta Psychiatr Scand. 2020 Jul 12. doi: 10.1111/acps.13212.
    PubMed     Abstract available


  40. TAKEUCHI H, Borlido C, Sanches M, Teo C, et al
    Adherence to Clozapine vs. Other Antipsychotics in Schizophrenia.
    Acta Psychiatr Scand. 2020 Jul 6. doi: 10.1111/acps.13208.
    PubMed     Abstract available


    May 2020
  41. VILLASANTE-TEZANOS AG, Rohde C, Nielsen J, de Leon J, et al
    Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-ressistant schizophrenia.
    Acta Psychiatr Scand. 2020 May 16. doi: 10.1111/acps.13184.
    PubMed     Abstract available


    April 2020
  42. MONTAG C, Brandt L, Lehmann A, de Millas W, et al
    Cognitive and Emotional Empathy in Individuals at Clinical High Risk of Psychosis.
    Acta Psychiatr Scand. 2020 Apr 27. doi: 10.1111/acps.13178.
    PubMed     Abstract available


    March 2020
  43. SISKIND D, Nielsen J
    Clozapine: a fine balance.
    Acta Psychiatr Scand. 2020;141:175-177.
    PubMed    


  44. KAROW A, Brettschneider C, Helmut Konig H, Correll CU, et al
    Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Acta Psychiatr Scand. 2020;141:221-230.
    PubMed     Abstract available


  45. RUBIO JM, Kane JM
    How and when to use clozapine.
    Acta Psychiatr Scand. 2020;141:178-189.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: